eriodictyol은 임신 중 안전한가요?

Related ingredients

Frequently asked questions

eriodictyol은 임신 중 안전한가요?

No harmonised CLP classification or SCCS/CIR safety assessment for eriodictyol was identified (ECHA Annex VI/CIR). Peer‑reviewed literature reports biological activity of the flavanone class and some in vitro estrogenic/ER‑modulating activity for flavonoids (PubMed), so a theoretical mechanism (weak endocrine activity) is possible, but there are no in vivo reproductive toxicity or human teratogenicity data specifically for eriodictyol (PubMed, PubChem). Topical systemic absorption is plausible but expected low for typical cosmetic use given the compound’s flavanone structure and polarity (PubChem).

eriodictyol은 모유 수유 중 안전한가요?

No evidence of reproductive or lactation hazards, no harmonised classification or CIR/SCCS opinion (ECHA Annex VI; CIR). Theoretical endocrine activity based on class/limited in vitro data supports a low mechanistic concern only (PubMed). Systemic exposure after topical application is expected low but measurable, so breastmilk exposure would be low (PubChem; no specific human PK data found).

eriodictyol은 아기 피부에 안전한가요?

No infant‑specific toxicity data or harmonised flags (ECHA Annex VI/CIR). Mechanistic concern remains theoretical only (flavonoid class in vitro activity) with no in vivo reproductive/developmental data for eriodictyol (PubMed). Dermal exposure concern is elevated for 0–3 yr due to higher skin permeability and surface‑area‑to‑weight ratio; if adult topical exposure is low but measurable (e=1), infant exposure is increased by +1 per guidance (PubChem, PubMed).

VeriMom은 eriodictyol을 어떻게 평가하나요?

VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 eriodictyol을 87/100 (낮은 위험)로 평가합니다.

임신 중 eriodictyol 대체 안전 성분은?

유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.